Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Peter Valent. (2007) Imatinib-resistant chronic myeloid leukemia (CML): Current concepts on pathogenesis and new emerging pharmacologic approaches. Biologics: Targets and Therapy 1:4, pages 433-448.
Read now
Read now
Takayuki Saitoh$suffix/text()$suffix/text(), Takafumi Matsushima, Hirono Iriuchishima, Arito Yamane, Hiroyuki Irisawa, Hiroshi Handa, Norifumi Tsukamoto, Masamitsu Karasawa, Yoshihisa Nojima & Hirokazu Murakami. (2006) Presentation of extramedullary Philadelphia chromosome-positive biphenotypic acute leukemia as testicular mass: Response to imatinib-combined chemotherapy. Leukemia & Lymphoma 47:12, pages 2667-2669.
Read now
Read now
Articles from other publishers (19)
Mhairi Copland. (2022) Treatment of blast phase chronic myeloid leukaemia: A rare and challenging entity. British Journal of Haematology 199:5, pages 665-678.
Crossref
Crossref
Mohammed Hussein Kamareddine, Youssef Ghosn, Antonios Tawk, Carlos Elia, Walid Alam, Joseph Makdessi & Said Farhat. (2019) Organic Nanoparticles as Drug Delivery Systems and Their Potential Role in the Treatment of Chronic Myeloid Leukemia. Technology in Cancer Research & Treatment 18, pages 153303381987990.
Crossref
Crossref
Akira Chiba, Takashi Toya, Hideaki Mizuno, Junji Tokushige, Fumihiko Nakamura, Kumi Nakazaki & Mineo Kurokawa. (2018) Chronic myelogenous leukemia presenting with central nervous system infiltration, successfully treated with central nervous system-directed chemotherapy followed by allogeneic stem cell transplantation. International Journal of Hematology 108:6, pages 640-646.
Crossref
Crossref
Joyce N. Mbekeani, Maaly Abdel Fattah, Randa M. Al Nounou, Wahiba Chebbo & Mohammed Asif Dogar. (2016) Chronic Myelogenous Leukemia Relapse Presenting With Central Nervous System Blast Crisis and Bilateral Optic Nerve Infiltration. Journal of Neuro-Ophthalmology 36:1, pages 73-77.
Crossref
Crossref
Juliana Gomez & Victor Duenas. (2015) Isolated Central Nervous System Relapse in Chronic Myeloid Leukemia. Case Reports in Medicine 2015, pages 1-4.
Crossref
Crossref
Chieh-Lin Jerry Teng, Jui-Ting Yu, Hung-Chieh Chen & Wen-Li Hwang. (2013) Maintenance therapy with dasatinib after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia. Annals of Hematology 92:8, pages 1137-1139.
Crossref
Crossref
Eudocia C. Quant, David C. Fisher & Patrick Y. Wen. 2012. Lymphoma and Leukemia of the Nervous System. Lymphoma and Leukemia of the Nervous System
357
381
.
Shih-Feng Cho, Ta-Chih Liu, Chi-Yu Lu & Chao-Sung Chang. (2010) Epidural leukemic involvement and intracranial hemorrhage as initial manifestations in a newly diagnosed chronic myeloid leukemia patient. Annals of Hematology 90:5, pages 607-609.
Crossref
Crossref
Peter Valent. (2010) Standard treatment of Ph+ CML in 2010: how, when and where not to use what BCR/ABL1 kinase inhibitor?. European Journal of Clinical Investigation 40:10, pages 918-931.
Crossref
Crossref
David J. Matthews & Mary E. Gerritsen. 2010. Targeting Protein Kinases for Cancer Therapy. Targeting Protein Kinases for Cancer Therapy
435
525
.
Peter Valent. (2010) Management of Chronic Myeloid Leukemia with BCR/ABL Inhibitors: Current Status and Future Perspectives. Clinical Medicine Insights: Therapeutics 2, pages CMT.S2439.
Crossref
Crossref
Hoiseon JeongBongkyung ShinSook Young BaeSangho LeeYoungjune RyuHankyeom KimInsun Kim. (2009) Extramedullary B Lymphoblastic Crisis of CML, Presenting as a Leptomeningeal Tumor - A Case Report -. The Korean Journal of Pathology 43:5, pages 482.
Crossref
Crossref
Changyoung YooYoun Soo LeeChang Suk KangSang In ShimKyo Young Lee. (2009) The Cytology for Leukemic Cells in Cerebrospinal Fluid; Comparison of Conventional Cytology with Liquid-Based Cytology. The Korean Journal of Pathology 43:2, pages 164.
Crossref
Crossref
Peter Valent, Thomas Lion, Dominik Wolf, Christian Sillaber, Hermine Agis, Andreas Petzer, Alois Lang, Peter Kalhs, Dietmar Geissler, Richard Greil, Werner Linkesch, Sonja Burgstaller, Josef Thaler & Günther Gastl. (2008) Diagnostic algorithms, monitoring, prognostication, and therapy in chronic myeloid leukemia (CML): a proposal of the Austrian CML platformDiagnostische Algorithmen, Prognose und Therapie in der Chronisch Myeloischen Leukämie (CML): Ein Proposal der Österreichischen CML-Plattform. Wiener klinische Wochenschrift 120:21-22, pages 697-709.
Crossref
Crossref
Peter Valent. (2008) Emerging stem cell concepts for imatinib-resistant chronic myeloid leukaemia: implications for the biology, management, and therapy of the disease. British Journal of Haematology 142:3, pages 361-378.
Crossref
Crossref
K. J. Aichberger, S. Herndlhofer, H. Agis, W. R. Sperr, H. Esterbauer, W. Rabitsch, P. Knöbl, O. A. Haas, R. Thalhammer, I. Schwarzinger, C. Sillaber, U. Jäger & P. Valent. (2007) Liposomal cytarabine for treatment of myeloid central nervous system relapse in chronic myeloid leukaemia occurring during imatinib therapy. European Journal of Clinical Investigation 37:10, pages 808-813.
Crossref
Crossref
Abdullah Altintas, Timucin Cil, Ilhan Kilinc, Muhammet Ali Kaplan & Orhan Ayyildiz. (2007) Central nervous system blastic crisis in chronic myeloid leukemia on imatinib mesylate therapy: a case report. Journal of Neuro-Oncology 84:1, pages 103-105.
Crossref
Crossref
Asumi YokotaShinya KimuraSatohiro MasudaEishi AshiharaJunya KurodaKiyoshi SatoYuri KamitsujiEri KawataYasuyuki DeguchiYoshimasa UrasakiYasuhito TeruiMartin Ruthardt, Takanori UedaKiyohiko HatakeKen-ichi InuiTaira Maekawa. (2006) INNO-406, a novel BCR-ABL/Lyn dual tyrosine kinase inhibitor, suppresses the growth of Ph+ leukemia cells in the central nervous system, and cyclosporine A augments its in vivo activity. Blood 109:1, pages 306-314.
Crossref
Crossref
Peter H. Wiernik. (2006) Plasma cell dyscrasias and leukemias. Update on Cancer Therapeutics 1:4, pages 539-567.
Crossref
Crossref